Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,563.06
-14.6682-0.93%
Number of Gainers:- -
Number of Losers:7
Number of Flat:- -
PE:- -
High:1,590.89
Open:1,579.34
Low:1,558.46
Close:1,578.03
Volume:33.48M
Turnover:2.39B
Market Cap:1.62T
Float Cap:1.57T

Loading ...

Nektar Therapeutics - Jury Finds Lilly Breached Implied Covenant of Good Faith in License Agreement - SEC Filing

THOMSON REUTERS
·
Sep 25

C4 Therapeutics Says Cemsidomide-Elranatamab Phase 1b Trial Clears 75 Μg Dose as Safe in Multiple Myeloma

Reuters
·
Sep 25

After Capital-Markets Day Flop, Novo Strikes Licensing Deal That Sends a Swedish Company's Stock Soaring

Dow Jones
·
Sep 25

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN) and Imunon (IMNN)

TIPRANKS
·
Sep 25

Novo Nordisk Licenses Nanexa Drug Delivery Technology

MT Newswires Live
·
Sep 25

Moderately bullish activity in Pfizer with shares up 0.9%

TIPRANKS
·
Sep 25

Cboe data shows mixed options sentiment in Novo Nordisk with shares up 0.96%

TIPRANKS
·
Sep 25

Viking Therapeutics Advances VK2735 Obesity Trial, Keeping VKTX in the Weight Loss Race

TIPRANKS
·
Sep 25

Pfizer’s Japanese RSV Vaccine Study Wraps Up, Expanding Adult Market Potential

TIPRANKS
·
Sep 25

Novo Nordisk A/S Series B Stock Rises Thursday, Outperforms Market

Dow Jones
·
Sep 25

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Sep 25

Pfizer call volume above normal and directionally bullish

TIPRANKS
·
Sep 24

Eli Lilly and Co Stock (LLY) Moved Up by 3.73% on Sep 24: A Full Analysis

TradingKey
·
Sep 24

Lilly's Next-Gen Obesity Efforts Could Tip Scales Further in Its Favor, Citi Says

Reuters
·
Sep 24

Viking Therapeutics Shares Down 15% After Co Prices Upsized Stock, Convertible Offerings

THOMSON REUTERS
·
Sep 24

U.S. Stocks on the MOVE-Everpure, Dropbox, Darden Restaurants

Reuters
·
Sep 24

Viking Therapeutics, - Offering Size Increased to $275 Mln Common Stock and $225 Mln Notes

THOMSON REUTERS
·
Sep 24

Eli Lilly Gets FDA OK for Onswik Once-Weekly Insulin Injection

Dow Jones
·
Sep 24

Eli Lilly - Onswik Kwikpen to be Available in U.S. in 500 Units/Ml and 1,000 Units/Ml Concentrations

THOMSON REUTERS
·
Sep 24

U.S. Food and Drug Administration (FDA) Approves Lilly's Onswik™ (Insulin Efsitora Alfa-Gobe), a Once-Weekly Basal Insulin Injection Treatment for Adults Living with Type 2 Diabetes

THOMSON REUTERS
·
Sep 24